After 8 years of leading Dana-Farber Cancer Institute, Laurie Glimcher, the first woman to serve as president and CEO, will step down on October 1. Benjamin Levine Ebert, current medical oncology chair, will take over. Under Glimcher’s leadership, Dana-Farber expanded, with increased patient volume and research support. Despite some controversies, including the decision to end a partnership with Brigham and Women’s Hospital and sitting on the GlaxoSmithKline board, Glimcher looks forward to mentoring and continuing her immunology research. Ebert will oversee the construction of a new hospital. Glimcher’s decision to step down was motivated by a desire to focus on research and spending time with her family.
Source link
Dana-Farber President, CEO Laurie Glimcher, MD, Steps Down
